David Estape, PhD

CRB Group
Senior Fellow - Biopharmaceutical Process
David Estapé, a long-time biotechnology expert who holds a doctorate in chemical engineering and has 25 years of experience in facility design and GMP consulting within the biotech, vaccine and blood plasma pharmaceutical segments. David has worked globally on major biotech projects of all sizes, from start-ups to lead pharmaceutical companies. With a strong interest in new technologies and regulatory trends, he participates heavily in organizations like BioPhorum and the International Society for Pharmaceutical Engineering. He works for CRB as the technology manager at the Basel office in Switzerland.

Related Articles

Applications of mRNA Technologies
iSpeak Blog
Applications of mRNA Technologies

mRNA is back at the 2022 ISPE Biotechnology Conference. Last year we learned from major key players about their journey to develop first time mRNA vaccines against COVID-19 and build manufacturing capacity for billions of doses in less than one year. In 2022 we are revising the relevance of mRNA technology and widening the view beyond the COVID vaccine.

Proof of Closure: Life Cycle of Closed Systems
Special Reports
Proof of Closure: Life Cycle of Closed Systems

This article was developed by members of the ISPE Biotechnology Community of Practice. The views and opinions are those of the authors and do not necessarily reflect the official policy or position of Hargrove Life Sciences, M+W, Novartis, Sandoz, Takeda, or any of their officers.